These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 25065974)

  • 21. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test.
    Sharma VK; Corder FA; Fancher J; Howden CW
    Am J Gastroenterol; 2000 Dec; 95(12):3629-32. PubMed ID: 11151904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disparities in the Participation Rate of Colorectal Cancer Screening by Fecal Occult Blood Test among People with Disabilities: A National Database Study in South Korea.
    Shin DW; Chang D; Jung JH; Han K; Kim SY; Choi KS; Lee WC; Park JH; Park JH
    Cancer Res Treat; 2020 Jan; 52(1):60-73. PubMed ID: 31096735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in screening for colorectal cancer--United States, 1997 and 1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Mar; 50(9):162-6. PubMed ID: 11393486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rural vs urban residence affects risk-appropriate colorectal cancer screening.
    Anderson AE; Henry KA; Samadder NJ; Merrill RM; Kinney AY
    Clin Gastroenterol Hepatol; 2013 May; 11(5):526-33. PubMed ID: 23220166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colorectal cancer screening practices among men and women in rural and nonrural areas of the United States, 1999.
    Coughlin SS; Thompson TD
    J Rural Health; 2004; 20(2):118-24. PubMed ID: 15085624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colorectal cancer test use among persons aged > or = 50 years--United States, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Mar; 52(10):193-6. PubMed ID: 12653456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes and cancer screening rates among Appalachian and non-Appalachian residents of Kentucky.
    Fleming ST; Love MM; Bennett K
    J Am Board Fam Med; 2011; 24(6):682-92. PubMed ID: 22086811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of colorectal cancer screening among adults--Behavioral Risk Factor Surveillance System, United States, 2010.
    Joseph DA; King JB; Miller JW; Richardson LC;
    MMWR Suppl; 2012 Jun; 61(2):51-6. PubMed ID: 22695464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in Breast and Colorectal Cancer Screening Adherence Among Women Residing in Urban and Rural Communities in the United States.
    Shete S; Deng Y; Shannon J; Faseru B; Middleton D; Iachan R; Bernardo B; Balkrishnan R; Kim SJ; Huang B; Millar MM; Fuemmler B; Jensen JD; Mendoza JA; Hu J; Lazovich D; Robertson L; Demark-Wahnefried W; Paskett ED;
    JAMA Netw Open; 2021 Oct; 4(10):e2128000. PubMed ID: 34605915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are we doing enough to screen for colorectal cancer? Findings from the 1999 Behavioral Risk Factor Surveillance System.
    Seeff LC; Shapiro JA; Nadel MR
    J Fam Pract; 2002 Sep; 51(9):761-6. PubMed ID: 12366896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of colorectal cancer tests--United States, 2002, 2004, and 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Mar; 57(10):253-8. PubMed ID: 18340331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in colorectal cancer test use in the medicare population, 1998-2005.
    Schenck AP; Peacock SC; Klabunde CN; Lapin P; Coan JF; Brown ML
    Am J Prev Med; 2009 Jul; 37(1):1-7. PubMed ID: 19423273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colorectal Cancer Screening Adherence in Selected Disabilities Over 10 Years.
    Deroche CB; McDermott SW; Mann JR; Hardin JW
    Am J Prev Med; 2017 Jun; 52(6):735-741. PubMed ID: 28214250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of patient-provider communication on colorectal cancer screening.
    Carcaise-Edinboro P; Bradley CJ
    Med Care; 2008 Jul; 46(7):738-45. PubMed ID: 18580394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Barriers to cancer screening for people with disabilities: a literature review.
    Merten JW; Pomeranz JL; King JL; Moorhouse M; Wynn RD
    Disabil Health J; 2015 Jan; 8(1):9-16. PubMed ID: 25096629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of colonoscopy for colorectal cancer screening: evidence from the 2000 National Health Interview Survey.
    Subramanian S; Amonkar MM; Hunt TL
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):409-16. PubMed ID: 15734966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Capacity for colorectal cancer screening by colonoscopy, Montana, 2008.
    Ballew C; Lloyd BG; Miller SH
    Am J Prev Med; 2009 Apr; 36(4):329-32. PubMed ID: 19285198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measuring the quality of colorectal cancer screening: the importance of follow-up.
    Etzioni DA; Yano EM; Rubenstein LV; Lee ML; Ko CY; Brook RH; Parkerton PH; Asch SM
    Dis Colon Rectum; 2006 Jul; 49(7):1002-10. PubMed ID: 16673056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of colorectal cancer screening uptake among men and women in the United States.
    Meissner HI; Breen N; Klabunde CN; Vernon SW
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):389-94. PubMed ID: 16492934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of colorectal cancer screening in veterans based on the location of primary care clinic.
    Malhotra A; Vaughan-Sarrazin M; Charlton ME; Rosenthal GE
    J Prim Care Community Health; 2014 Jan; 5(1):24-9. PubMed ID: 24327586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.